Loading news...
Core Laboratories Inc. (NYSE: CLB - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $15.60 and traded as high as $16.29. Core Laboratories shares last traded at $15.8820, with a volume of 330,035 shares trading hands. Wall Street Analysts Forecast
Investors interested in Oil and Gas - Field Services stocks are likely familiar with Drilling Tools International Corp. (DTI) and Core Laboratories (CLB). But which of these two stocks presents investors with the better value opportunity right now?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
CLB shows strong international demand, free cash flow generation and a solid financial position, but near-term U.S. land activity challenges and margin pressure could limit growth.
Core Laboratories (NYSE: CLB) reported fourth-quarter and full-year 2025 results that reflected modest top-line growth, continued shareholder returns, and a mix of strength in international demand alongside weakness in U.S. land activity. Management emphasized that demand for the company's proprietary technologies helped offset a seasonally soft U.S. land market, while geopolitical tensions, evolving sanctions, and commodity
CLB expects revenues to range from $124 million to $130 million and earnings per share to be between 11 cents and 15 cents for the first quarter of 2026.
Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript
Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.22 per share a year ago.
HOUSTON, Feb. 4, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported fourth quarter 2025 revenue of $138,300,000. Core's operating income was $15,800,000, with earnings per diluted share ("EPS") of $0.15, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $15,700,000, yielding operating margins of over 11% and EPS, ex-items, of $0.21. For the full year 2025, revenue of $526,500,000 was up slightly compared to 2024, generating operating income on a GAAP basis of $56,500,000 and operating income, ex-items, of $58,700,000. The Company's full year EPS, ex-items, was $0.75. A full reconciliation of non-GAAP financial measures is included in the attached financial tables.
CLB is expected to report higher revenues than the year-ago period's level. However, it is expected to have faced increased costs and expenses.
Investors interested in Oil and Gas - Field Services stocks are likely familiar with Halliburton (HAL) and Core Laboratories (CLB). But which of these two companies is the best option for those looking for undervalued stocks?
Arkadios Wealth Advisors reduced its holdings in Core Laboratories Inc. (NYSE: CLB) by 41.9% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 49,297 shares of the oil and gas company's stock after selling 35,599 shares during the period. Arkadios Wealth Advisors owned
CLB shows consistent growth, a strong market position and proprietary tech, but faces challenges like cost pressure, international risks and high valuation concerns.
HOUSTON, Jan. 5, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2025 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on February 5, 2026.
Ariel Investments LLC lifted its position in shares of Core Laboratories Inc. (NYSE: CLB) by 25.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,976,463 shares of the oil and gas company's stock after acquiring an additional 2,634,438 shares
Fisher Asset Management LLC lowered its position in shares of Core Laboratories Inc. (NYSE: CLB) by 14.2% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 867,726 shares of the oil and gas company's stock after selling 143,838 shares during the
CLB benefits from long-term industry investments and strong acquisitions, though its growth is modest and vulnerable to macroeconomic and geopolitical uncertainties.
Tetra Technologies (NYSE: TTI - Get Free Report) and Core Laboratories (NYSE: CLB - Get Free Report) are both small-cap energy companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership. Insider and Institutional Ownership 70.2% of Tetra
Campbell and CO Investment Adviser LLC acquired a new position in shares of Core Laboratories Inc. (NYSE: CLB) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 25,831 shares of the oil and gas company's stock, valued at approximately $298,000. Campbell and CO
Envestnet Asset Management Inc. boosted its holdings in shares of Core Laboratories Inc. (NYSE: CLB) by 11.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 282,871 shares of the oil and gas company's stock after purchasing an additional